Avanex in the Spotlight
19332
Profits and cash flows are within reach for this high-tech upstart.
578661
Basel, Switzerland, November 30 (ots/PRNewswire) - Roche and Genentech, Inc., announced today that Avastin(TM) (bevacizumab, rhuMAb-VEGF), a new innovative anti-angiogenesis drug, has shown for the first time that it significantly increases survival in
210679
IT security distributor Trans Niaga Sdn Bhd recently formed an alliance with global e-security company Authenex Inc to undertake extensive marketing and distribution of the latter's products and services.
77029
Now that Merck &amp; Co.&#39;s $2.5 billion annual revenues from anti-inflammatory COX-2 inhibitor VIOXXÂ® are history, the next question is what happens to the even greater amount of money ($3.
556057
Interpublic Group is getting more connected to telephony company Avaya, which has added one more IPG agency to its roster and bulked up its interactive business at another--assignments that sources estimated to be worth a total of &#36;15 million in billings.
629482
The Motley Fool - Yesterday, I wrote about how everyone and their neighbor seems to gunning for a slice of Apple's (Nasdaq: AAPL - News) iPod and iTunes business. And while I still believe it's possible for News Corp.'s (NYSE: NWS - News) MySpace, Microsoft (Nasdaq: MSFT - News), and Sony (NYSE: SNE - News) to erode some of Apple's market share for downloadable music, I don't expect the company to passively stand by as revenues drop.
631592
A report last week tying the Type 2 diabetes pill Avandia to increased risk for heart attack and heart-related deaths prompted a flood of calls to local doctors and Internet postings from patients seeking advice about whether to continue taking the commonly prescribed medication.
276323
Avaya's sell-out to private equity firms may be a sign of sustained growth in telecom.
678087
The real issue users need to keep their eyes on is will these three companies be able to leave well enough alone. How other companies have handled past acquisitions might provide some insight into how these company mergers and their products will fare long term.
730876
GlaxoSmithKlineâs effort to focus Avandiaâs marketing on African-Americans could backfire as questions arise.
536024
Research and Markets (http://www.researchandmarkets.com/reports/c46706)  has announced the addition of Spotlight on Television 2.0 Leaders: AT&T  Inc. to their offering.
326837
Last weekâs dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this weekâs lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patientsâ health.
516107
WASHINGTON - GlaxoSmithKline PLC's Avandia, the world's best-selling diabetes drug last year, will carry US regulators' strongest warning on the risk of heart attacks.
164906
The latest studies on Avandia, GlaxoSmithKline's blockbuster diabetes drug, have raised enough questions about the drug's safety to worry the American Diabetes Association.
306697
Telecommunications equipment maker Avaya Inc.  is in talks with private equity and strategic bidders about selling all or part of the company, according to a report by The Wall Street Journal.
262304
Shares of Genentech Inc. DNA.N, OSI  Pharmaceuticals Inc. OSIP.O and ImClone Systems Inc. IMCL.O  surged before the bell on Friday after rival AstraZeneca Plc  AZN.L said its lung cancer drug Iressa failed to show  survival benefits in a major clinical study.
165412
Enablex, also known as darifenacin, was approved by the Food and Drug Administration. Novartis (nyse: NVS - news - people ) had purchased the drug from Pfizer (nyse: PFE - news - people ) for $225 million